Impacts

Researchers will use TIA facilities and expertise to advance their work to discover a targeted medicine that boosts the immune system to fight cancer. They

Innovation in Australia’s health and medical research translation has been boosted with National Collaborative Research Infrastructure Strategy (NCRIS)- enabled health and medical research partners signing

Research in areas such as cancer, autoimmune disease, endometriosis, mental health, kidney disease and bacterial infection will advance with almost $500,000 in support from Therapeutic

Australian science continues to make national and international headlines, most recently focusing on the COVID-19 pandemic and the 2019 – 2020 Australian bushfires. Behind these

We are delighted to announce the outcomes of the first round of Pipeline Accelerator 2021-22 scheme. A total of $560,000 will be invested to support

AIBN Professor Trent Munro is part of a new biotechnology company aiming to treat Type 2 diabetes using saliva from parasitic worms. Professor Munro has

AUCKLAND: COVID-19 Vaccination Corporation (CVC), New Zealand’s most experienced group of vaccine researchers have joined forces with Australia’s BASE Nucleic Acids Biomanufacturing Facility to produce

TIA supports and facilitates researcher and SME access to a diverse range of Australian translational medical research infrastructure (see Table 1) via a voucher-style scheme

The Biologics Innovation Facility (BIF) in collaboration with PerkinElmer have established a training facility to assist local biotech companies and academia to have access to